P. Dogterom
发表
G. Mulder,
J. Nagelkerke,
P. Dogterom,
1988,
Biochemical pharmacology.
P. Dogterom,
P. Peeters,
R. Greef,
2013,
European Journal of Clinical Pharmacology.
Y. Plétan,
M. Jandrot-Perrus,
M. Machacek,
2019,
Arteriosclerosis, thrombosis, and vascular biology.
J. Dingemanse,
M. Ufer,
P. Dogterom,
2020,
Clinical and translational science.
Y. Plétan,
M. Machacek,
P. Dogterom,
2020,
Journal of clinical pharmacology.
A. Aleman,
D. Colas,
Y. Godfrin,
2022,
Neurology and Therapy.
K. Lasseter,
T. Marbury,
P. Dogterom,
2011,
Clinical pharmacokinetics.
N. Vermeulen,
G. Mulder,
D. Meijer,
1986,
The Journal of pharmacology and experimental therapeutics.
G. Zbinden,
P. Dogterom,
G. Reznik,
1992,
Critical reviews in toxicology.
A. Aleman,
D. Colas,
Y. Godfrin,
2022,
Neurology and Therapy.
G. Mulder,
J. Nagelkerke,
P. Dogterom,
1989,
Chemico-biological interactions.
P. Dogterom,
J. Jonkman,
S. Vallance,
1999
.
L. Squassante,
P. Dogterom,
J. Jonkman,
1999,
European Journal of Clinical Pharmacology.
G. Mulder,
J. van Steveninck,
J. Nagelkerke,
1988,
Chemico-biological interactions.
B. van de Water,
G. Mulder,
J. Nagelkerke,
1991,
Hepatology.
Jialin Xu,
H. Waskin,
P. Dogterom,
2015,
Antimicrobial Agents and Chemotherapy.
P. Dogterom,
C. Fu,
T. Legg,
2018,
Drug development and industrial pharmacy.
F. Kesisoglou,
A. Mitra,
P. Dogterom,
2015,
AAPS PharmSciTech.
Valproate Reduces the Glucuronidation of Asenapine Without Affecting Asenapine Plasma Concentrations
P. Dogterom,
P. Peeters,
R. Greef,
2012,
Journal of clinical pharmacology.
E. Kroese,
A. Noach,
J. Nagelkerke,
1990,
Biochemical pharmacology.
A. Vliet,
P. Dogterom,
P. Peeters,
2012,
Clinical pharmacology in drug development.
Erik A. Meulman,
T. de Boer,
J. Wieling,
2012,
Biomedical chromatography : BMC.
E. Kroese,
L. Bree,
F. Zitman,
1987,
Pharmaceutisch Weekblad.
Erik A. Meulman,
T. de Boer,
J. Wieling,
2012,
Biomedical chromatography : BMC.
G. Mulder,
P. Dogterom,
1993,
Chemico-biological interactions.
E. Kroese,
G. Mulder,
J. Nagelkerke,
1989,
Biochemical pharmacology.
P. Dogterom,
1993,
Drug metabolism and disposition: the biological fate of chemicals.
R. Bursi,
J. Schipper,
L. Ereshefsky,
2012,
Journal of psychopharmacology.
R. Bursi,
J. Schipper,
L. Ereshefsky,
2012,
Drugs in R&D.
R. Findling,
M. Troyer,
V. Reddy,
2018,
Drug design, development and therapy.
J. Dingemanse,
M. Ufer,
P. Dogterom,
2019,
Clinical and translational science.
G. Bianchetti,
P. Dogterom,
J. Jonkman,
1998,
Fundamental & clinical pharmacology.
L. Ereshefsky,
A. Port,
P. Dogterom,
2009
.
G. Mulder,
J. Nagelkerke,
P. Dogterom,
1989,
The Biochemical journal.
C. O. Kamlin,
K. Weiss,
P. Dogterom,
2021,
European Journal of Drug Metabolism and Pharmacokinetics.
R. Bursi,
M. Hutmacher,
J. Schipper,
2011,
Psychopharmacology.
T. Thomsen,
P. Dogterom,
M. W. Heuvel,
2005,
Clinical pharmacokinetics.
F. Kesisoglou,
A. Mitra,
P. Dogterom,
2015,
AAPS PharmSciTech.
E. Liu,
C. Barlow,
S. Sankaranarayanan,
2023,
Clinical pharmacology in drug development.
P. Dogterom,
P. Peeters,
R. Greef,
2013,
European Journal of Clinical Pharmacology.
P. Dogterom,
P. Peeters,
C. Timmer,
2008,
European Neuropsychopharmacology.
J. Rothuizen,
P. Dogterom,
1993,
Drug metabolism and disposition: the biological fate of chemicals.
Allyl Alcohol and Acrolein Toxicity in Isolated Rat Hepatocytes is Independent of Lipid Peroxidation
G. Mulder,
J. Nagelkerke,
P. Dogterom,
1988
.
R. Bursi,
J. Schipper,
L. Ereshefsky,
2012,
Journal of psychopharmacology.